Translate
Beam Therapeutics Inc.
About
Beam Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
Mar 25 2026
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
Feb 24 2026
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
Feb 24 2026
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
Feb 23 2026
Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program
Recent Videos
BEAM, Beam Therapeutics Inc., 2026-04-27, stock prices dynamics, stock of the day
Apr 28, 2026
🔥 외국인이 쓸어담는 Beam Therapeutics Inc., Fastly, Inc., 지금 당장 확인하세요 | 2026.04.27 미국 장중 실시간
Apr 27, 2026
BEAM, Beam Therapeutics Inc., 2026-04-10, stock prices dynamics, stock of the day
Apr 12, 2026
How to Invest in Beam Therapeutics Inc. (BEAM) Step by Step
Apr 11, 2026